Literature DB >> 17374437

Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?

Richard J Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17374437     DOI： 10.1016/j.eururo.2007.03.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate.

Authors:  Peter Stanislaus; Dirk Zaak; Thomas Stadler; Stefan Tritschler; Ruth Knüchel; Christian G Stief; Alexander Karl
Journal:  World J Urol       Date:  2010-06-26       Impact factor: 4.226

2.  Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.

Authors:  Vincenzo Serretta; Francesco Sommatino; Cristina Scalici Gesolfo; Vito Franco; Giuseppe Cicero; Rosalinda Allegro
Journal:  Urol Ann       Date:  2015 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.